CORPORATE ACCESS

Action being taken after CE mark expirationExpects negative impact to full-year 2019 revenue of approximately two percent WINTER SPRINGS, Fla., Jan. 22, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging...

WINTER SPRINGS, Fla., Dec. 19, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices, today announced FDA 510(k) clearance of its 3883 MRI-compatible invasive blood pressure module for...

Reports third quarter 2018 revenue of $7.6 millionReports third quarter 2018 GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.14Increases full year 2018 revenue, GAAP and non-GAAP diluted earnings guidance WINTER SPRINGS, Fla., Oct. 30, 2018 -- IRADIMED...

WINTER SPRINGS, Fla., Oct. 16, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 third quarter financial results before the market opens on Tuesday, October 30th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., Sept. 11, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices, today announced receipt of regulatory clearance from the Japanese Ministry of Health Labor &...

Reports second quarter 2018 revenue of $7.4 millionReports second quarter 2018 GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.14Increases full year 2018 revenue, GAAP and non-GAAP diluted earnings guidance WINTER SPRINGS, Fla., July 31, 2018 -- IRADIMED...

WINTER SPRINGS, Fla., July 16, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 second quarter financial results before the market opens on Tuesday, July 31st. IRADIMED management will host a conference call the same...

Reports first quarter 2018 revenue of $7.1 millionReports first quarter 2018 GAAP diluted EPS of $0.07 and non-GAAP diluted EPS of $0.10Increases full year 2018 GAAP and non-GAAP diluted EPS guidance WINTER SPRINGS, Fla., April 30, 2018 -- IRADIMED CORPORATION...

WINTER SPRINGS, Fla., April 16, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 first quarter financial results before the market opens on Monday, April 30th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., March 05, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer, will present at the 30th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled to present on Monday, March...